Specify a stock or a cryptocurrency in the search bar to get a summary
Psyence Group Inc
PSYGPsyence Group Inc., a life science biotechnology company, engages in the cultivation and production of commercial psilocybin mushroom. It operates in two segments: Clinical Trial Activities and Non-Clinical Trial Activities. The company natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. The company was founded in 2019 and is based in Toronto, Canada. Address: 121 Richmond Street West, Toronto, ON, Canada, M5H 2K1
Analytics
WallStreet Target Price
0.77 CADP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures PSYG
Dividend Analytics PSYG
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PSYG
Stock Valuation PSYG
Financials PSYG
Results | 2019 | Dynamics |